Erschienen in:
01.12.2001 | Paper Report
Tamoxifen, angiogenesis, oestrogens and animal models
verfasst von:
Valerie Speirs
Erschienen in:
Breast Cancer Research
|
Ausgabe 1/2000
Einloggen, um Zugang zu erhalten
Excerpt
Angiogenesis is the remodelling of existing vasculature either by formation of new blood vessels or regression of superfluous vessels. In normal adults there is relatively little angiogenesis, but it is well documented that neovascularisation is required for tumour growth beyond a critical size. The (ER) antagonist TAM is currently the first line therapy for treatment of hormone sensitive breast cancer. However, besides its anti-oestrogenic effects, TAM has also been shown to have anti-angiogenic properties. Although there has been much work on the former, the anti-angiogenic actions of TAM are not well understood. …